Donepezil for mild cognitive impairment in Parkinson’s disease
Abstract We investigated the efficacy of donepezil for mild cognitive impairment in Parkinson’s disease (PD-MCI). This was a prospective, non-randomized, open-label, two-arm study. Eighty PD-MCI patients were assigned to either a treatment or control group. The treatment group received donepezil for...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/39f7c08a31db49eb80b91afbe4c66e31 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|